Chargement en cours...
Next-generation prognostic assessment for diffuse large B-cell lymphoma
Current standard of care therapy for diffuse large B-cell lymphoma (DLBCL) cures a majority of patients with additional benefit in salvage therapy and autologous stem cell transplant for patients who relapse. The next generation of prognostic models for DLBCL aims to more accurately stratify patient...
Enregistré dans:
| Publié dans: | Future Oncol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4644669/ https://ncbi.nlm.nih.gov/pubmed/26289217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon.15.144 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|